Nonprofit scientists head to industry.

The article reports on the decisions of several top researchers to leave academic and government posts for jobs in the pharmaceutical industry. Drug company Novartis hired Mark C. Fishman, a Harvard Medical School professor, as the president of its Novartis Institutes for BioMedical Research (NIBR) in Cambridge, Massachusetts. Ron Malachuk, a principal at executive search firm Korn Ferry, attributed the trend to efforts of drugmakers to develop intellectual property and increase innovation.